Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 901–1,000 of 1,000
Réssio, R. A. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-03112010-165617
Regulation of cellular signalling pathways by Adenovirus
Forrester, N. A. (2012) · University of Birmingham Institutional Research Archive (University of Birmingham)
Debatin, K. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_6
Hypoxia Is Responsible for Changes in Cellular Constraints During Inflammation
Schwartz, L. H. (2004) · Springer eBooks · doi:10.1007/978-3-642-18543-4_6
Structural and functional studies of growth arrest and DNA-damage proteins
Bhattacharya, S. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12064
A review of in vitro and in vivo models of oesophageal and gastric cancer
Mukherji, D., & Benepal, T. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903410203
“It has been observed that cyclin D1 expression and p53 inactivation are the most frequently observed genetic alterations in oesophageal squamous cancers promoting cell cycle progression, genomic instability and decreasing growth arrest in response to genotoxic stress [48].”
BackgroundUnderstanding Cancer at the Genomic Level
Xu, Y., Cui, J., & Puett, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1381-7_4 · Cited by 1
Activation of mitogen-activated protein kinase pathway by extremely low-dose ionizing radiation
Suzuki, K., Kodama, S., & Watanabe, M. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)01201-9
The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers
Ali, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3512
“Chk1 activates p53 in response to DNA damage through direct phosphorylation of Ser15 and Ser20 (Qu et al., 1997; Shieh et al., 2000), thus protecting p53 from MDM2mediated proteasomal degradation (Honda et al., 1997; Lakin & Jackson, 1999).”
BackgroundTHE ATTENUATION OF THE P53 RESPONSE TO DNA DAMAGE IN RODENT LIVER PRENEOPLASTIC ENZYME- ALTERED FOCI
Finnberg, N. K. (2003) · Figshare
DigitalCommons@Th e Texas Medical Center
Gsbs, U., & Hong, J. Y. (2011)
Valle‐Mendiola, A., & Steider, B. W. (2003) · Vertientes. Revista Especializada en Ciencias de la Salud
Aberrations of DNA Damage in Checkpoints in Cancer
Laiho, M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_5
Regulation of apoptosis by mar binding protein smar1
Sinha, S. (2009) · INFLIBNET
Hosako, H. (2009) · OakTrust (Texas A&M University Libraries)
Utilising omics approaches to understand Kaposi's sarcoma-associated herpesvirus
Owen, C. B. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
An investigation of p53’s differential activation of cell cycle arrest and apoptosis
Zhang, Y. (2008) · eSpace (Curtin University)
Sorrentino, J. A. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/jsmf-v470
Joy, J. K. (2006) · Max Planck Institute for Plasma Physics
Hołownia, A., Mróz, R. M., Kozłowski, M., Chyczewska, E., Laudanski, J., Chyczewski, L., & Braszko, J. J. (2007) · Advances in respiratory medicine · doi:10.5603/arm.27973
“Dane z piśmiennictwa wskazują na potranslacyjne modyfikacje p53 w trakcie terapii, ale są one niewystarczające [14, 18, 25].”
BackgroundMolekulare Pathologie bösartiger pulmonaler und pleuraler Tumoren
Müller, K., Wiethege, T., Krismann, M., Junker, K., & Johnen, G. (2002) · Springer eBooks · doi:10.1007/978-3-642-56297-6_2
Pozzi, M. (2011) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/pozzi-marco_phd2011-01-17
The role of MITF in the regulation of CDKN2A in melanoma
Andreassen, R. C. (2017) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Control hipotalámico de las interacciones neuroendocrinas
Lizarbe, B., & Cerdán, S. (2013) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.13039/501100003329 · Cited by 1
Vila, A. (2018) · DalSpace (Dalhousie University)
Brooks, C. (2009) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2009-09101
Adams, L. M. (2017) · Figshare
Characterization of pellino1 and pellino2 in toll-like receptor signaling
Dai, L. X. (2012) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/50864
Natural Genetic Variation Underlying UVR Sensitivity in Drosophila melanogaster
Chana, K. (2015) · Figshare
Rogowski, K. J. (2020) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-27117
“The significance of TP53 for safeguarding the genome is underscored by the fact that it has been reported to be one of the most frequently mutated genes in human cancers (Lakin and Jackson 1999).”
BackgroundCharacterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage
Haider, N. (2018) · TSpace (University of Toronto) · Cited by 1
Robust Transcriptional Regulatory Response Upon Blocking NHEJPreprint
Benjamin, R., Banerjee, A., Guerunk, C., Buczek, L., Eames, D., Trimidal, S. G., & Schiller, M. R. (2021) · Research Square · doi:10.21203/rs.3.rs-459760/v1
Ives, R., & Gandhi, K. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.262
P53 Alterations in Human Skin: A Molecular Study Based on Morphology
Gao, L. (2001) · Uppsala University Publications (Uppsala University) · Cited by 1
Breedon, S. A. (2021) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2021-14738
The role of αA-crystallin and lnc-TMPRSS15 when human lens epithelial cells exposed to dexamethosonePreprint
Wang, L., Wang, Y., Zhao, W., & Liu, P. (2022) · Research Square · doi:10.21203/rs.3.rs-1226704/v1
Cell Cycle Checkpoints: Signal Transmission and Effector Targets
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. E. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch21
Monsalve, D. M. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124182 · Cited by 1
Lai, S., Higuchi, T., Tsuda, M., Sugiyama, Y., Morisawa, K., Taniguchi, T., & Sakamoto, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12600-y · Cited by 1
TP53-status dependent oncogenic EZH2 Activity in Pancreatic Cancer
Versemann, L. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9359
Modulation of HSF1 activity by p53 and its impact in cancer therapies
Isermann, T. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9996
Splicing inhibition as a post-transcriptional stress
Vanzyl, E. J. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15484
Meevassana, J., Mutirangura, A., Angspatt, A., Hamill, K. J., & Sheridan, C. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.24 · Cited by 1
Sarkar, A. (2024) · Advances in Clinical Toxicology · doi:10.23880/act-16000291
Poquet, A. (2022) · theses.fr (ABES) · doi:10.70675/137768e8zc055z4098zb500zf904e8347893 · Cited by 1
Suppression of Homologous Recombination by RAD51 Functional Inactivation In Vivo in Mice
Matos-Rodrigues, G. E. (2020) · theses.fr (ABES) · doi:10.70675/6c3cf7f3za3a0z4ed4z97a2zeb1353824f3d
The molecular and cellular consequences of AsiDNA™ combined with radiotherapy on healthy tissue
Sesink, A. (2023) · theses.fr (ABES) · doi:10.70675/9c9c5f80z9a52z4360z803cz9131e6e43fd3 · Cited by 1
de la Concha, M. J., Barnes, P. E., Mwikali, K., Ng, B. L., Mondal, B., Khatavkar, M., Ponstingl, H., & Pance, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.05.611436
“…(CTD) domains (Andreas C. Joerger and Fersht, 2010; Brady and Attardi, 2010) In steady-state p53 is maintained at very low levels due to its short half-life and thermodynamic instability, rapidly unfolding at body temperature which results in inefficient DNA binding (Lakin and Jackson, 1999).”
Jana, P. K., Sil, S., Ghosh, A., Sultana, I., & Chattopadhyay, S. (2025) · Discover Toxicology · doi:10.1007/s44339-025-00023-z
Nishiyama, Y., Sonoyama, Y., Wang, B., Ghosh, S., Sharath Krishnan, P. V., Sasatani, M., Shimokawa, T., Aoki, S., & Morita, A. (2025) · Radiation and Environmental Biophysics · doi:10.1007/s00411-025-01146-y
“The tumor suppressor p53 plays a central role in maintaining genomic integrity in response to DNA damage, particularly that induced by ionizing radiation (Lowe et al. 1993; Lakin and Jackson 1999).”
Haider, S. A., Shahid, S., Sarfaraz, I., Yousaf, B., Azhar, S., & Majeed, M. N. (2025) · Research Square · doi:10.21203/rs.3.rs-7618330/v1
Radiation Sensitivity for BRCA Mutation Carriers
Yoshida, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-6779-6_4
RECQL4 as a novel drug target against ovarian cancer
Qin, Y., Li, L., Yu, J. H., Cheng, S., Pan, W., Yang, Y., & Luo, H. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117520
Ross, I. A. (2025) · Springer eBooks · doi:10.1007/978-3-032-04239-2_14
The Future of Molecular Neuro-Oncology
King, J., & Taylor, M. D. (2009) · Springer eBooks · doi:10.1007/978-3-540-69960-6_194
The role of NUCKS in DNA repair
Hume, S. (2016) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-xokwyd0zm
p53 REGULATES METABOLISM BY BOTH TRANSCRIPTION-DEPENDENT AND TRANSCRIPTION-INDEPENDENT FUNCTIONS
Sanford, J. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ys4y-he09
Analysis of Neil DNA glycosylases during early Xenopus development
Han, D. (2019) · Gutenberg Open Science · doi:10.25358/openscience-3757
Le-Trung, N., Duong, T. M., Dang, T. T. P., & Kamei, K. (2023) · Figshare · doi:10.6084/m9.figshare.23994608
Le-Trung, N., Duong, T. M., Dang, T. T. P., & Kamei, K. (2023) · Figshare · doi:10.6084/m9.figshare.23994611
Characterization of planarian adult pluripotent stem cells by single-cell transcriptome analysis
黒木, 義., クロキ, ヨ., & KUROKI, Y. (2024) · SOKENDAI (Graduate University for Advanced Studies)
Innovation de nouvelles formulations pour moduler la chimiothérapie du cancer du sein triple négatif
Belmessabih, N. (2023) · Corpus Université Laval (Université Laval)
Genomics assessment of the impact of ionising radiation on the human brain
Ofosu-Dankwa, J. (2025) · Brunel University Research Archive (BURA) (Brunel University London)
The genotoxicity of polychlorinated biphenyls (PCBs)
Βορδώνη, Ε. Κ., & Μακρή, Α. Α. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Jung, Y., Kim, S. S., Park, S., Jeong, D., Gu, J.-Y., Lee, J.-S., Kim, S. Y., Chang, Y. H., Seong, M., Yun, H., et al. (2025) · Leukemia Research · doi:10.1016/j.leukres.2025.108156
Peculiar Cat with Many Lives: PUMA in Viral Infections
Wyżewski, Z., Stępkowska, J., Pruchniak, P., Niedzielska, A., Gregorczyk-Zboroch, K. P., & Mielcarska, M. B. (2026) · Cells · doi:10.3390/cells15030278
“Under physiological conditions, the level of p53 remains low due to strict regulation by its negative regulators [34,35].”
Deshpande, S., Li, W. F., Song, J., Forsberg, M., Cerchione, C., Martinelli, G., & Konopleva, M. Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1735418 · Cited by 4
“These proteins promote ubiquitination and subsequent proteasomal degradation of p53, maintaining its low basal levels in unstressed cells (30 – 32).”
Yoon, H., Park, J.-M., Han, J., Kwon, Y., & Jang, K. L. (2026) · Cells · doi:10.3390/cells15050415
“This phosphorylation disrupts the MDM2-p53 complex, stabilizing p53 by preventing MDM2-mediated ubiquitination [11,13,14].”
Décryptage du rôle de TP53INP1 dans la suppression de tumeur
N’guessan, P. (2011) · theses.fr (ABES) · doi:10.70675/e1fbbdb4zb427z4b4cz90ebz6da200b25b35
Tichet, M. (2013) · theses.fr (ABES) · doi:10.70675/22b4e5efz84fdz4c9cz88d0zdcf7f372747b
Engineered Surface Metal Organic Frameworks (MOFs) for Encapsulation and Delivery of Macromolecules
Hidalgo, T. (2015) · theses.fr (ABES) · doi:10.70675/2234f611z722ez44d5z97d2z13d484003da4 · Cited by 1
Rôle de la protéine de réparation de l'ADN Ku dans la régulation traductionnelle de l'ARNm p53
Lamaa, A. (2015) · theses.fr (ABES) · doi:10.70675/84827579z033ez4898z91f3z8bffc0f1e897
The role of PKD in mitochondrial fission during mitosis
Bielska, O. (2018) · theses.fr (ABES) · doi:10.70675/2dbab59fze200z4e37z9770zea1c8f1345ea · Cited by 1
Diallo, M. (2016) · theses.fr (ABES) · doi:10.70675/9108845cz2c2az480dz99cdzc3cfab68f50b
NMR study of 14-3-3 protein-protein interactions and modulation thereof by small molecules
Neves, J. F. (2019) · theses.fr (ABES) · doi:10.70675/6952dbaezebb9z4212z9c01z6ea8f2190a06
Identification of a new regulator and a new function of cellular senescence
Ma, X. (2018) · theses.fr (ABES) · doi:10.70675/491c2a61z0065z4672z8799ze9aa650f23fd
APOBEC3A cytidine deaminase, a potent mutator enzyme leading to nuclear DNA damages
Li, X. (2018) · theses.fr (ABES) · doi:10.70675/c6c54ef9za374z4871zb0e0z9d11e8ea3d84
Fonctions et régulations de la kinase CHK1 dans l'hématopoïèse normale et leucémique
Cartel, M. (2019) · theses.fr (ABES) · doi:10.70675/7824b06fz5467z4c2cz89c1zf5bed2a53f34
Gautier‐Isola, M. (2020) · theses.fr (ABES) · doi:10.70675/b7e26a71za1e0z48e7za416z5e837ae7e8ef · Cited by 1
Vers des quantum dots moins toxiques, une approche "safer by design"
Dussert, F. (2020) · theses.fr (ABES) · doi:10.70675/7a3d2314z807az4db8z889azcaefd37efcde
EVT-701 : targeting electron transport chain complex I as therapeutic approach in cancer
Yolba, R. L. (2021) · theses.fr (ABES) · doi:10.70675/9cadea77z03ccz4a54zb381zf34a432615a5 · Cited by 2
Metalloprotease-mediated cleavage of CD95 ligand
Risso, V. (2022) · theses.fr (ABES) · doi:10.70675/36a21870z79bbz4fa6z89edzc2eb46de8295
Belhadef, A. (2023) · theses.fr (ABES) · doi:10.70675/91702b52zca5az4b04zaf8cz97331b9d3751
Deciphering the role of the telomere-mitochondria connections during senescence
Lin, P. (2024) · theses.fr (ABES) · doi:10.70675/5437405ez9ab8z4656zab11z024ef945decd
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.